Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

被引:1
作者
Aurélien Philippe
Richard Chocron
Nicolas Gendron
Olivier Bory
Agathe Beauvais
Nicolas Peron
Lina Khider
Coralie L. Guerin
Guillaume Goudot
Françoise Levasseur
Christophe Peronino
Jerome Duchemin
Julie Brichet
Elise Sourdeau
Florence Desvard
Sébastien Bertil
Frédéric Pene
Cherifa Cheurfa
Tali-Anne Szwebel
Benjamin Planquette
Nadia Rivet
Georges Jourdi
Caroline Hauw-Berlemont
Bertrand Hermann
Pascale Gaussem
Tristan Mirault
Benjamin Terrier
Olivier Sanchez
Jean-Luc Diehl
Michaela Fontenay
David M. Smadja
机构
[1] Université de Paris,
[2] Innovative Therapies in Haemostasis,undefined
[3] INSERM,undefined
[4] 75006 Paris,undefined
[5] France,undefined
[6] Hematology Department and Biosurgical Research Lab (Carpentier Foundation),undefined
[7] Assistance Publique Hôpitaux de Paris. Centre-Université de Paris (APHP.CUP),undefined
[8] Université de Paris,undefined
[9] PARCC,undefined
[10] INSERM,undefined
[11] Emergency Department,undefined
[12] Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP),undefined
[13] Université de Paris,undefined
[14] Emergency department,undefined
[15] Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP),undefined
[16] Université de Paris,undefined
[17] Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP),undefined
[18] Université de Paris,undefined
[19] Vascular Medicine Department and Biosurgical Research Lab (Carpentier Foundation),undefined
[20] Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP),undefined
[21] Université de Paris,undefined
[22] Innovative Therapies in Haemostasis,undefined
[23] INSERM,undefined
[24] 75006 Paris,undefined
[25] France,undefined
[26] Curie Institute,undefined
[27] Cytometry department,undefined
[28] Université de Paris,undefined
[29] Innovative Therapies in Haemostasis,undefined
[30] INSERM,undefined
[31] 75006 Paris,undefined
[32] France,undefined
[33] Respiratory Medicine Department and Biosurgical Research Lab (Carpentier Foundation),undefined
[34] Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP),undefined
[35] Université de Paris,undefined
[36] Innovative Therapies in Haemostasis,undefined
[37] INSERM,undefined
[38] 75006 Paris,undefined
[39] France,undefined
[40] Hematology Department Assistance Publique Hôpitaux de Paris.Centre-Université de Paris (APHP-CUP),undefined
[41] Université de Paris,undefined
[42] PARCC,undefined
[43] INSERM,undefined
[44] 75015 Paris,undefined
[45] France,undefined
[46] Vascular medicine department,undefined
[47] Assistance Publique - Hôpitaux de Paris-Centre (APHP-CUP),undefined
[48] Université de Paris,undefined
[49] PARCC,undefined
[50] INSERM U970,undefined
来源
Angiogenesis | 2021年 / 24卷
关键词
Endothelial activation; COVID-19; Von Willebrand factor; Multimers; Mortality; Microthrombosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:505 / 517
页数:12
相关论文
共 127 条
[1]  
Debuc B(2020)Is COVID-19 a new hematologic disease? Stem Cell Rev Rep 10 15-3044
[2]  
Smadja DM(2020)COVID-19 is, in the end, an endothelial disease Eur Heart J 41 3038-2040
[3]  
Libby P(2020)COVID-19 and its implications for thrombosis and anticoagulation Blood 135 2033-1062
[4]  
Lüscher T(2020)Curative anticoagulation prevents endothelial lesion in COVID-19 patients J Thromb Haemost 18 2391-1418
[5]  
Connors JM(2020)Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost 18 1520-13
[6]  
Levy JH(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet Lond Engl 395 1054-1034
[7]  
Khider L(2020)Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and Front. Med. 7 20-799
[8]  
Gendron N(2020)-dimer and correlation with right ventricular afterload Lancet Lond Engl 395 1417-1772
[9]  
Goudot G(2020)Endothelial cell infection and endotheliitis in COVID-19 Eur Respir J 55 1900933-e582
[10]  
Tang N(2020)Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases J. Infect. Dis. 222 1789-2437